AN2 Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
AN2 Therapeutics, Inc. has filed 369 SEC EDGAR filings since 24 Sep 2021

SEC filing history

Showing 151-175 of 369 matching filings.

Per page
25
Current page
7
SC 13G/A File 005-93617

AMENDMENT NO. 1

Filing date
28 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-41331

8-A12B

Filing date
19 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
15 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
15 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93617

SC 13G/A filing

Filing date
14 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Aug 2024
Reporting date
14 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93617

SC 13G/A

Filing date
13 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Aug 2024
Reporting date
09 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
12 Aug 2024
Reporting date
09 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93617

SC 13G filing

Filing date
12 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jul 2024
Reporting date
10 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93617

SC 13G filing

Filing date
03 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Jun 2024
Reporting date
19 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .